Besides dialysis and kidney transplantation after reaching End Stage Renal Disease (ESRD), only one drug is approved for the treatment of ADPKD. Tolvaptan modestly slows CKD progression in ADPKD but has significant side effects and toxicities and is only available to a subset of patients worldwide...